He's Best Known for The Fault in Our Stars. That His Latest Book Is About the World's Deadliest Disease Actually Makes Perfect Sense.
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily.
Henry Reider talks like his words can't keep up his thoughts. It makes sense. English is his third language after Krio and Mende—all of which are spoken in his native Sierra Leone. Reider is also a creative, whose mind dances between anything from his university studies to his YouTube channel, or to whatever it is he's talking about at the time.
While he speaks to me from his home in Sierra Leone, a rooster crows in the background, punctuating his sentences like a barnyard hype man. Rather than distract from what he's saying, though, it makes it seem all the more important. He's excited and passionate. He speaks quickly, as if he might not ever get the chance to say the words again. If I didn't know any better, I would never have guessed that, just a few years ago, Henry Reider nearly died being choked to death by his own lungs.
'People should understand that tuberculosis is not just a disease of the past,' Reider told me. 'It is still affecting millions of people today, but it is preventable, treatable, and also curable.'
Reider's journey of how he contracted and (spoilers) ultimately recovered from multidrug-resistant TB is told in Everything Is Tuberculosis: The History and Persistence of Our Deadliest Infection by John Green. The book, which was published last week, tells the story of the disease and how it molded—and continues to shape—human history.
The book might seem, at first blush, like a departure for Green, who's best known for his bestselling young adult novels, such as The Fault in Our Stars and Looking for Alaska along with his cleverly packaged memoir The Anthropocene Reviewed. But Everything Is Tuberculosis is, in many ways, a quintessential John Green book: one that grapples with the issue of mortality and our conflicting desires to both help and hurt one another, all within the backdrop of the coming of age of a young man, Reider.
Reider met Green when he was 17 years old at the Lakka Government Hospital in Freetown, Sierra Leone. The author was there to learn about the country's maternal care system as part of his support for the global health nonprofit Partners in Health. Reider, now 25, acts as the book's heart and hero, giving the reader a view into his life that's both intimate and, often, unbearable to witness. We must witness it, though, the book insists. We must witness the pain, and the fleeting but precious moments of joy. We must witness Reider's struggles to find medicine and keep his torturous hunger at bay, and his near-superhuman ability to maintain hope throughout it all.
While his story is the frame, the book also dives into the scientific and cultural history of tuberculosis, told with the intelligence, wit, and tragedy that have become hallmarks of the author's work. In this book, Green acts as a kind of exasperated Ms. Frizzle, if Ms. Frizzle lived in Indianapolis and seemed to only wanted to talk about TB. The approach works, letting the reader learn about the disease in fun ways ('Did you know tuberculosis gave us the cowboy hat?') but also underscoring the horrific unfathomability of TB ('Still, over a million people died of tuberculosis in 2023. That year, in fact, more people died of TB than died of malaria, typhoid, and war combined.').
Above all else, though, the book is an attempt to make the case for TB's relevance today. Despite the fact that many believe that the infection is a thing of the past—think cowboy Arthur Morgan coughing in Red Dead Redemption 2 or Fantine wasting away in Les Misérables—tuberculosis is still very much with us. In 2023, 10.8 million people worldwide were infected by the disease, according to the World Health Organization. In the same year, a total of 1.25 million people died as a result, making it the world's deadliest disease. From 2020 through 2022, it was second only to COVID-19.
Everything Is Tuberculosis doesn't so much tell you the story of tuberculosis, as much as it gently holds your hand and parts the curtains into one of the darkest, most bizarre, and frustrating series of decisions in world history with the other. After all, Green often reminds us, that's what tuberculosis is: a decision.
Even with drug-resistant TB, the disease is highly treatable—so it's a decision to let people die when we know how to cure their infection. It's a decision to allow the disease to spread and flourish when we cut funding. It's a decision to let TB feed and grow on human lives and communities, the way a fire might devour a forest. It's a decision to let people go untreated when pharmaceutical companies charge exorbitant premiums for lifesaving medicine for the sake of the bottom line.
And it was a decision to let Henry Reider nearly die of tuberculosis.
Tuberculosis kills you in different ways. Contracted via airborne particles, it can cause respiratory failure, damaging and scarring your lungs to the point where breathing can be like trying to suck air through a plastic coffee stirrer. It can also cause major bleeding in your lungs to the point where you cough up and, eventually, drown to death in your own blood.
It takes a while for the disease to get to this point. In fact, some become infected with TB for years before they start developing symptoms. The standard treatment is intensive, requiring patients to take a regimen of around six to nine pills a day (sometimes more) for about six months. However, it's very effective, with success rates ranging around 90 percent. Of course, it can be expensive, with treatments costing upwards of $20,000 for a full course. International aid programs like USAID often provide the medicine free of charge, but those efforts aren't enough.
Tuberculosis can develop quickly and viciously with the right conditions like those most often faced in communities throughout the 'Global South' such as poverty, malnutrition, and lack of access to medicine—conditions that Reider was and is regularly exposed to. This causes a domino effect, one that can exacerbate and worsen an already nightmarish situation.
'If the drugs are not available to those people who need them, it can lead to death,' Reider explained. 'People won't be able to handle it when funding is cut off. When you are funding something, and you cut off that funding, it can lead to unnecessary death.'
In the book, Green talks about the concept of a 'good death,' noting that our concept of good and bad ways of dying have constantly shifted over the years. In the past, Western society romanticized tuberculosis (colloquially known as 'consumption'). It was the way great poets, artists, and philosophers died. People thought it even made you more beautiful the way it made one's skin glow with fever and the body waifish and willowy as it starved.
Today, we would never consider dying of TB to be a 'good death.' The reality is it's painful and exhausting. Often, in places like Sierra Leone, there's so much stigma attached to TB that those infected are treated as social outcasts by even their family members. As such, patients often die alone in underfunded and under-resourced hospitals like the one Reider was in when Green met him.
Yet every day we allow people like him to die of tuberculosis even though countries like the U.S. have nearly unfettered access to lifesaving treatments and vaccines. 'When the resources are available for treatment, it can prevent everything,' Reider said. 'It can also lead to awareness. More people will understand that the disease is dangerous, and that treatment is available.'
It's a terrible bind: TB isn't hard to treat; we decide to let it go untreated. When I call John Green, he talks like words just aren't enough anymore—which is ironic for a man who has made his living writing novels. Sitting in the basement of his Indianapolis home in the room where he films the majority of his videos for his and his brother Hank Green's popular and long-running YouTube channel Vlogbrothers, he looks and sounds like the embodiment of the phrase 'I'm getting too old for this shit.'
'I am discouraged,' is what he tells me when I ask him how he's doing. Reider, he says, 'loves to use the words 'encouraged' and 'discouraged,' and the way that he uses them reminds me that courage is a verb. Courage is something we rouse ourselves and each other into, or courage is something that we pull away from. And right now, I feel pretty discouraged.'
Green has plenty of reasons to feel discouraged—the U.S. government seems outright hostile to any efforts to support global health. President Donald Trump, along with his unelected billionaire hatchet man Elon Musk, has announced they would shut down USAID, which is also the largest bilateral donor in the fight against tuberculosis. On March 10, U.S. Secretary of State Marco Rubio—who is also the acting director of the agency—announced that the White House cut 83 percent of programs under USAID.
Musk also took an ax to the Centers for Disease Control and Prevention. His Department of Government Efficiency team has fired roughly 1,300 employees at the agency (or 10 percent of the CDC overall), including 135 members of the Epidemic Intelligence Service. As many as 1,500 employees at the National Institutes of Health were also laid off by DOGE in February.
Meanwhile, tuberculosis is spreading in America. After 30 years of decline, TB infections in the U.S. have risen every year since the pandemic. This is not a coincidence. As Green notes in his book, TB is a crisis that flourishes when there are other crises, including malnutrition, poor health care infrastructure, stigma surrounding the disease, poverty, and other infectious diseases such as HIV, Ebola, or COVID-19. A recent outbreak of the disease in Kansas City, Kansas, resulted in the deaths of two people with 67 being treated for active infections and 79 people with latent infections.
For good and ill, all of these reasons have made Everything Is Tuberculosis perhaps the most relevant of the nine books Green has written or co-written—a fact that doesn't escape him. 'The defunding of USAID and other human health programs by the United States government in such a chaotic way has been absolutely devastating to human health,' Green said. 'The choices that are being made right now are going to send us backwards as a species, and that's devastating.'
He added, 'The story of humanity should be a slow but persistent march toward more just and equitable human-built systems, and right now we're making the opposite choice.'
Everything Is Tuberculosis is his way of grappling with this choice, and what happens when we do not, collectively, make the correct choice. A passage early on in the book sums it up well: 'But we cannot save those we love from suffering. This is the story of human history as I understand it—the story of an organism that can do so much, but cannot do what it most wants.' We as humans are organisms helpless against our worst qualities.
That's part of what Green wants most out of this book: to bring awareness to something that society has ignored for reasons that are all at once human and frustrating. If there's anything that we've learned from the COVID-19 pandemic and the way that people brush it aside and ignore it even though it's still happening, it's that we don't like to think about disease.
'I think we solve the problems we pay attention to, and for too long we haven't paid attention to the global tuberculosis crisis,' Green said. 'That's the reason we haven't solved it.'
Henry Reider talks like someone who escaped death. He spent nearly all of his formative years in hospital beds throughout Sierra Leone before finally being treated and cured. Now, having escaped his death, he's determined to live a full, rich, and good life. That means completing his university studies, growing his YouTube channel, and taking care of his mom. He told me he wants to become a 'great journalist and philanthropist' so he too can tell stories and change lives the way that Green did for him.
'I want to advocate,' Reider said. 'My connection with my friend John has created an atmosphere for me to advocate for those who have been in the same situation as me but have much less connections or support. So, I want to advocate for and motivate any individual who's sick and needs help out there, because I know when someone is in that same situation, they need support.'
As I read Everything Is Tuberculosis, a line from another book kept echoing in my head: 'So we beat on, boats against the current, borne back ceaselessly into the past.' Humanity has a boundless capacity for so much joy and pain. Yet we nearly always find ourselves repeating the mistakes of our past over and over again. This is the story of us. This is the story of our relationship with this disease.
Tuberculosis has been with humans for at least 9,000 years. We have an older relationship with TB microbes than we do with writing, horses, and the Great Pyramids of Egypt. We only learned how to cure the disease much more recently, in 1943, but in 2023 we still allowed 1.25 million people to die of it. Green notes in the book, it would take $25 billion dollars on comprehensive care a year to 'drive tuberculosis toward elimination.' This is money easily accessible and available to some people in the United States.
There is zero excuse to allow people to die the same way today that they have for 9,000 years. And yet, no matter how hard we row the boat, we can't escape the past. We get dragged back into it, endlessly and ceaselessly.
But we keep going. We wake up. We eat. We take care of our parents. We go to school. We make YouTube videos about our lives and dream of becoming journalists and advocates. We meet wonderful and interesting people, and we write books about them. We get sick. We get better. We fight to make sure that others don't get sick ever again, even if the very country we live in is working against us.
We do everything we can—because we believe that people deserve nothing less than everything we have.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community
HHS Interrupts "The Most Cost-Beneficial Intervention In Healthcare" UPPER NYACK, N.Y., June 10, 2025--(BUSINESS WIRE)--Yesterday, the Secretary of Health and Human Services (HHS) removed all sitting members of the Advisory Committee on Immunization Practices (ACIP), the expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine use. While the groups such as the Global Healthy Living Foundation (GHLF) recognize the Secretary's right to do this, the decision made just ahead of the upcoming respiratory virus season puts at risk chronically ill patients who rely on vaccines to fight respiratory virus infections. ACIP is often critical in shaping public health strategies with its advisory recommendations. While the FDA-approved label remains the definitive, enforceable standard for how vaccines should be used in clinical practice, ACIP guidance often informs insurance company coverage, determines whether vaccines are free under the Affordable Care Act, provides healthcare provider protocols, and helps ensure vaccination campaign success , especially for vulnerable populations. "Removing the entire committee without immediate replacement or clear guidance creates uncertainty when COVID-19, flu, and RSV are expected to circulate widely in the coming months," said Robert, Popovian, PharmD, MS, GHLF's Chief Science Policy Officer. "Now is the time when the advisory committee makes its recommendations, and disruption in the advisory process could have profound implications for individuals with chronic illnesses who depend on timely vaccine access to protect themselves against these viruses. "We support the need for ACIP to remain independent, and we recognize the Secretary's authority to appoint new members," Dr. Popovian added. "But removing all members without naming successors or offering a timeline to replace them so close to respiratory season could delay essential recommendations. "Vaccines are the most cost-beneficial intervention in healthcare—we should do everything possible to maintain uninterrupted access to expert guidance including ensuring there is no gap in expert advice during this critical period for immunization planning," Dr. Popovian added. About GHLF The Global Healthy Living Foundation is a U.S. based, 501(c)(3) nonprofit, international organization whose mission is to improve the quality of life for people with chronic illnesses by advocating for improved access to health care through education, patient-centered clinical research, support, advocacy, and economic and policy research. GHLF is also a staunch advocate for vaccines. The Global Healthy Living Foundation is the parent organization of CreakyJoints®, the international, digital community for millions of people living with arthritis and their supporters worldwide who seek education, support, activism, and patient-centered research in English, Spanish, and French. In addition to arthritis and autoimmune disorders, GHLF supports dermatology, gastroenterology, neurology, cardiology, oncology, infectious disease, rare disease, and pulmonary patients through a host of different programs and activities which draw more than 700,000 patients a month to GHLF websites and create more than 10 million impressions a month on seven social media platforms. In 2024, GHLF had more than 1 million views and listens with its patient-centered audio-visual content, found on YouTube and podcast platforms. GHLF never asks the public for donations, receiving funding instead through governments, non-governmental organizations, foundations, industry, family foundations, and GHLF Co-Founder Louis Tharp. Visit for more information. View source version on Contacts Louis TharpLTHARP@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
an hour ago
- Business Wire
Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community
BUSINESS WIRE)--Yesterday, the Secretary of Health and Human Services (HHS) removed all sitting members of the Advisory Committee on Immunization Practices (ACIP), the expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine use. Vaccines are the most cost-beneficial intervention in healthcare While the groups such as the Global Healthy Living Foundation (GHLF) recognize the Secretary's right to do this, the decision made just ahead of the upcoming respiratory virus season puts at risk chronically ill patients who rely on vaccines to fight respiratory virus infections. ACIP is often critical in shaping public health strategies with its advisory recommendations. While the FDA-approved label remains the definitive, enforceable standard for how vaccines should be used in clinical practice, ACIP guidance often informs insurance company coverage, determines whether vaccines are free under the Affordable Care Act, provides healthcare provider protocols, and helps ensure vaccination campaign success , especially for vulnerable populations. 'Removing the entire committee without immediate replacement or clear guidance creates uncertainty when COVID-19, flu, and RSV are expected to circulate widely in the coming months,' said Robert, Popovian, PharmD, MS, GHLF's Chief Science Policy Officer. 'Now is the time when the advisory committee makes its recommendations, and disruption in the advisory process could have profound implications for individuals with chronic illnesses who depend on timely vaccine access to protect themselves against these viruses. 'We support the need for ACIP to remain independent, and we recognize the Secretary's authority to appoint new members,' Dr. Popovian added. 'But removing all members without naming successors or offering a timeline to replace them so close to respiratory season could delay essential recommendations. 'Vaccines are the most cost-beneficial intervention in healthcare—we should do everything possible to maintain uninterrupted access to expert guidance including ensuring there is no gap in expert advice during this critical period for immunization planning,' Dr. Popovian added. About GHLF The Global Healthy Living Foundation is a U.S. based, 501(c)(3) nonprofit, international organization whose mission is to improve the quality of life for people with chronic illnesses by advocating for improved access to health care through education, patient-centered clinical research, support, advocacy, and economic and policy research. GHLF is also a staunch advocate for vaccines. The Global Healthy Living Foundation is the parent organization of CreakyJoints®, the international, digital community for millions of people living with arthritis and their supporters worldwide who seek education, support, activism, and patient-centered research in English, Spanish, and French. In addition to arthritis and autoimmune disorders, GHLF supports dermatology, gastroenterology, neurology, cardiology, oncology, infectious disease, rare disease, and pulmonary patients through a host of different programs and activities which draw more than 700,000 patients a month to GHLF websites and create more than 10 million impressions a month on seven social media platforms. In 2024, GHLF had more than 1 million views and listens with its patient-centered audio-visual content, found on YouTube and podcast platforms. GHLF never asks the public for donations, receiving funding instead through governments, non-governmental organizations, foundations, industry, family foundations, and GHLF Co-Founder Louis Tharp. Visit for more information.
Yahoo
3 hours ago
- Yahoo
US aid cuts threaten South Africa's status as powerhouse of HIV and tuberculosis research
South Africa risks losing its status as a powerhouse of HIV and tuberculosis research as sweeping American funding cuts jeopardise dozens of experimental trials. At least 27 HIV trials and another 20 TB trials in the country have been put at risk by Donald Trump's deep cuts to foreign assistance and global health spending, new analysis shows. Loss of the trials would hit research projects looking for new vaccines into both infections, as well as new long-lasting protective medicines and studies into the best way to treat children. Having intense HIV and TB epidemics as well as world class universities and research institutes has made South Africa a leader in combating the two diseases. Yet while the research has often been led by South African scientists, it has overwhelmingly been conducted with international funding, particularly with 20 years of generous United States government aid spending. Prof Salim Abdool Karim, director of the Centre for the Aids Program of Research in South Africa, said: 'The US is such a big player in our country – South Africa is a powerhouse in medical research because of what the US spends.' The bulk of funding for research came from the US National Institutes of Health (NIH), with the country receiving an estimated £111m ($150m) each year. Prof Ntobeko Ntusi, the president and chief executive of the South African Medical Research Council (SAMRC), said earlier this year: 'In many ways the South African health research landscape has been a victim of its own success, because for decades we have been the largest recipients of both [official development assistance] funding from the US for research [and] also the largest recipients of NIH funding outside of the US.' Now, unless alternative sources of money can be found, South African academic and research institutes could lose about 30 per cent of their annual income and may be forced to lay off hundreds of staff, the analysis found. 'There's been a huge dependence on US funding. The loss of it for South Africa means the cancellation of a huge amount of research,' said Tom Ellman, director of the MSF's Southern Africa Medical Unit (SAMU). The joint analysis by Treatment Action Group (TAG) and Doctors Without Borders (MSF) of NIH-funded research found 39 TB and HIV clinical research sites are under threat, placing at least 27 HIV trials and 20 TB trials at risk. The effect of cuts could be wider still, with research also funded through other US channels, including the US President's Emergency Plan for Aids Relief (Pepfar), which has been slashed by Donald Trump's administration. Lindsay McKenna, TB project co-director of TAG said: 'Public funding from the US government to South Africa is the scaffold on which pharmaceutical companies, philanthropies, and other governments invest in transformative TB and HIV science.' 'These ongoing funding disruptions by the US government don't just affect US-funded research projects, they put in peril a much wider ecosystem of global research.' Dr Ellman said a combination of the infections found in South Africa, its research base and its strong grass roots activism had combined, with US funding, to make the country so prominent in research. He said: 'For years, South Africa has spearheaded the research and development of critical innovative medical tools for the prevention, diagnosis, treatment and care of HIV and TB which have saved lives not just within South Africa's borders, but also in communities worldwide.' The country has more HIV patients than any other, with an estimated 8 million currently infected and 105,000 deaths annually. The high prevalence of HIV goes hand-in-hand with a high prevalence of tuberculosis, because TB takes advantage of patients' weakened immune systems. Tuberculosis is the biggest cause of death among those with HIV in South Africa, which recorded 54,000 TB deaths in 2023. At the same time, the country has strong research institutions and universities, and a history of medical innovation, including conducting the first heart transplant in 1969. Finally, the history of the apartheid struggle, and later the fight in the early 2000s to get antiretroviral drugs in the face of government AIDS denialism, has produced well-organised and politically-engaged health activists. According to the joint analysis, HIV trials now at risk include studies into using broadly neutralising antibodies (bNAbs) to find a cure, and also trials into long-lasting anti-HIV preventative jabs. The Brilliant Consortium, a collaboration of African researchers led by the SAMRC working to develop an HIV vaccine, lost all funding even as it was about to begin an early stage vaccine trial. Dr Ellman said: 'I think it would be a disaster if we gave up on the hope of finding an effective vaccine for HIV. All of that has been done with South Africa and without access to South African research and communities, it's not going to be possible.' The emergence of some resistance to antiretroviral drugs has also highlighted the importance of trials to find new drugs which can deal with the phenomenon. HIV trials are also looking at honing and improving existing treatment regimes, as well as simplifying and rolling out expensive techniques first used in the developing world. TB trials at risk include studies for new drugs and shorter, safer regimens for treatment and prevention. The cuts have a ripple effect beyond individual trials, because they also weaken research infrastructure which is used and relied on by other funders. That could have a knock-on effect on trials looking at new TB jab possibilities, including the promising new M72/AS01E vaccine candidate. South Africa is now scrabbling for alternative sources of funding to try to salvage as many of the research projects as possible. Dr Ellman said: 'We call on all potential donors to step up, as without sustained investment, we will never end these deadly epidemics.' Protect yourself and your family by learning more about Global Health Security Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.